公开(公告)号：EP4360104A1

公开(公告)日：2024-05-01

申请号：EP22750937.9

申请日：2022-06-22

申请人： Abbott Diabetes Care, Inc.

发明人： TAUB, Marc B. ,  KIAIE, Namvar

IPC分类号： G16H40/67 ,  G16H50/50

CPC分类号： G16H40/67 ,  G16H50/50

公开(公告)号：EP3668400A2

公开(公告)日：2020-06-24

申请号：EP18769490.6

申请日：2018-08-17

申请人： Abbott Diabetes Care Inc.

发明人： SCOTT, Steven ,  BENNELL, Christopher J. ,  BHOGAL, Claire ,  CRANFIELD, Katie A. ,  TAUB, Marc B. ,  WINTER, Bree M. ,  REYNOLDS, Owen D. ,  BABKA, Jean-Pierre ,  PATEL, Dharmendra S. ,  THOMAS, Christopher A. ,  HOSS, Udo ,  YAHNKE, Mark S. ,  KAHN, Tahir S.

IPC分类号： A61B5/145 ,  A61B5/1495

公开(公告)号：EP2925404A1

公开(公告)日：2015-10-07

申请号：EP13859365.2

申请日：2013-11-27

申请人： Abbott Diabetes Care, Inc.

发明人： SLOAN, Mark K. ,  CHENG, Royce ,  HAYTER, Gary A. ,  TAUB, Marc B. ,  GOPAL, Mani

IPC分类号： A61N1/08

CPC分类号： A61B5/145 ,  A61B5/14503 ,  A61B5/14532 ,  A61B5/1495 ,  A61B5/7221 ,  A61B2560/029 ,  A61B2562/08 ,  G06F19/00 ,  G16H10/40 ,  G16H40/63

摘要： Generally, methods, devices, and systems related to analyte monitoring and data logging are provided—e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived—e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.

公开(公告)号：EP4360103A1

公开(公告)日：2024-05-01

申请号：EP22744045.0

申请日：2022-06-22

申请人： Abbott Diabetes Care Inc.

发明人： TAUB, Marc B. ,  KIAIE, Namvar

IPC分类号： G16H40/67 ,  G16H50/50

CPC分类号： G16H40/67 ,  G16H50/50

公开(公告)号：EP4331659A3

公开(公告)日：2024-04-24

申请号：EP23205132.6

申请日：2013-11-27

申请人： Abbott Diabetes Care, Inc.

发明人： SLOAN, Mark K. ,  CHENG, Royce ,  HAYTER, Gary A. ,  TAUB, Marc B. ,  GOPAL, Mani

IPC分类号： A61B5/145 ,  A61B5/1495 ,  A61N1/08

CPC分类号： A61B5/7221 ,  A61B5/14503 ,  A61B5/14532 ,  A61B2560/02920130101 ,  A61B5/1495 ,  A61B2562/0820130101 ,  G16H40/63 ,  G16H10/40

摘要： Generally, methods, devices, and systems related to analyte monitoring and data logging are provided - e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived- e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.

公开(公告)号：EP4288970A1

公开(公告)日：2023-12-13

申请号：EP22704843.6

申请日：2022-02-02

申请人： Abbott Diabetes Care Inc.

发明人： HAYTER, Gary A. ,  BHATTACHARYA, Aparajita ,  BUDIMAN, Erwin S. ,  NOVAK, Matthew T. ,  JIN, Taihao ,  TAUB, Marc B. ,  FERN, Jonathan M. ,  XU, Yongjin ,  ZHU, Kaiyuan ,  COVINGTON, Kendall ,  COOK, Kelly ,  FLOEH, Jessica Rose ,  BOSCO, Rosina ,  CHARLESWORTH, Taylor M. ,  PARTHASARATHY, Vyshnnavi

IPC分类号： G16H20/17 ,  G16H50/20

公开(公告)号：EP4218568A1

公开(公告)日：2023-08-02

申请号：EP23163721.6

申请日：2018-08-17

申请人： Abbott Diabetes Care Inc.

发明人： SCOTT, Steven ,  BENNELL, Christopher J. ,  BHOGAL, Claire ,  CRANFIELD, Katie A. ,  TAUB, Marc B. ,  WINTER, Bree M. ,  REYNOLDS, Owen D. ,  BABKA, Jean-Pierre ,  PATEL, Dharmendra S. ,  Thomas, Christopher A. ,  HOSS, Udo ,  YAHNKE, Mark S. ,  KAHN, Tahir S.

IPC分类号： A61B5/145 ,  A61B5/1495

摘要： An analyte monitoring system, comprising a sensor control device and an on-body electronics unit. The sensor control device has an in vivo analyte sensor adapted to sense a level of an analyte in vivo, wherein a first portion of the in vivo sensor is configured to be positioned beneath a skin surface of a user in a subcutaneous space and a second portion of the in vivo sensor is configured to remain outside the user. The on-body electronics unit is communicatively coupled with the in vivo analyte sensor and comprises a non-transitory memory, wherein individualized calibration information is stored in the memory, wherein the individualized calibration information is based on a representation of a measured manufacturing parameter of the in vivo analyte sensor, and wherein the individualized manufacturing parameter is an electrical characteristic and is specific to the in vivo analyte sensor.

公开(公告)号：EP4007523A1

公开(公告)日：2022-06-08

申请号：EP20851137.8

申请日：2020-07-31

申请人： Abbott Diabetes Care Inc.

发明人： HAYTER, Gary A. ,  BHATTACHARYA, Aparajita ,  BUDIMAN, Erwin S. ,  NOVAK, Matthew T. ,  JIN, Taihao ,  TAUB, Marc B. ,  FERN, Jonathan M. ,  XU, Yongjin ,  ZHU, Kaiyuan ,  COVINGTON, Kendall

IPC分类号： A61B5/00 ,  A61B5/0205 ,  A61B5/022 ,  A61B5/1455

公开(公告)号：EP2433235A2

公开(公告)日：2012-03-28

申请号：EP10732523.5

申请日：2010-05-21

申请人： Abbott Diabetes Care, Inc.

发明人： BUDIMAN, Erwin S. ,  HAYTER, Gary A. ,  CROUTHER, Nathan ,  TAUB, Marc B. ,  HARPER, Wesley Scott ,  WEI, Charles

IPC分类号： G06F19/00

CPC分类号： A61M5/1723 ,  A61B5/14532 ,  A61B5/1495 ,  A61B5/4839 ,  A61B2562/0295 ,  A61M2005/14208 ,  A61M2005/14296 ,  A61M2205/3569 ,  A61M2205/52 ,  A61M2230/201 ,  G06F19/00 ,  G06F19/3468

摘要： Safety features are applied to an integrated insulin delivery system to enhance safety while accounting for glucose sensor bias and calibration errors. One safety feature includes comparisons of calibrations of the sensor to nominal sensitivity and taking action, such as limiting insulin delivery or taking a further calibration of the sensor. In another feature, an automatic resumption of a basal delivery rate is programmed into the delivery device to avoid the possibility of complete loss of delivery of insulin in the event that communication with the delivery device is disrupted. Other features include steps taken to avoid hypoglycemia in the event that the sensor is negatively biased.

公开(公告)号：EP4331659A2

公开(公告)日：2024-03-06

申请号：EP23205132.6

申请日：2013-11-27

申请人： Abbott Diabetes Care, Inc.

发明人： SLOAN, Mark K. ,  CHENG, Royce ,  HAYTER, Gary A. ,  TAUB, Marc B. ,  GOPAL, Mani

IPC分类号： A61N1/08

摘要： Generally, methods, devices, and systems related to analyte monitoring and data logging are provided - e.g., as related to in vivo analyte monitoring devices and systems. In some aspects, methods, devices, and systems are provided that relate to enable related settings based on an expected use of an in vivo positioned sensor; logging or otherwise recording analyte levels acquired or derived- e.g., sample analyte levels more frequently than they are logged or otherwise recorded in memory; dynamically adjust the data logging frequency; randomly determine times of acquiring or storing analyte levels from the in-vivo positioned analyte sensors; and enable recording related settings when the system is operable.